Anthony E Maida Iii Oncotelic Therapeutics, Inc. (OTLC) insider trading activity

OTLC Quotes by TradingView

Anthony E Maida Iii is Chief Clin. Ops. Officer of Oncotelic Therapeutics, Inc.. Currently has a direct ownership of 1.14 Million shares of OTLC, which is worth approximately $22,746. The most recent transaction as insider was on Mar 31, 2021, when has been sold 938,646 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.14M
0% 3M change
0% 12M change
Total Value Held $22,746

ANTHONY E MAIDA III Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2021
BUY
Conversion of derivative security
-
938,646 Added 45.22%
1,137,314 Common Stock
AEM

Anthony E Maida Iii

Chief Clin. Ops. Officer
Agoura Hills,, CA

Track Institutional and Insider Activities on OTLC

Follow Oncotelic Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OTLC shares.

Notify only if

Insider Trading

Get notified when an Oncotelic Therapeutics, Inc. insider buys or sells OTLC shares.

Notify only if

News

Receive news related to Oncotelic Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OTLC